High systemic LDL cholesterol levels during experimental osteoarthritis lead to increased synovial activation and ectopic bone formation at end-stage osteoarthritis, while excessive levels accelerate development of joint pathology already at early-stage of osteoarthritis  by de Munter, W. et al.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A284Purpose: The infrapatellar fat pad (IPFP) is commonly resected during
knee joint arthroplasty. This longitudinal study examined the associa-
tions between the maximum cross-sectional area (CSA) of the IPFP and
knee cartilage volume and pain in adults without knee osteoarthritis
(OA).
Methods: 297 adults without baseline knee pain or a diagnosis of knee
OA had MRI performed at baseline and follow-up (n ¼ 271). IPFP
maximal CSA and tibial cartilage volume were measured from MRI.
Body composition was performed at baseline using bio-impedance.
Knee pain was assessed at follow-up using the Western Ontario and
McMaster University Osteoarthritis Index (WOMAC).
Results: A larger IPFP at baselinewas associatedwith reduced knee pain
at follow-up (OR 0.5, 95% CI: 0.3 to 0.9, p ¼ 0.02) and lateral tibial
cartilage volume loss (b: -0.9% (95% CI: -1.6, -0.1%) per annum, p¼ 0.03).
The maximal CSA of the IPFP was predominantly located in the lateral
(54.2%), rather than the medial tibiofemoral compartment (1.7%). Male
gender (OR 12.0, 95% CI: 6.5 to 22.0, p < 0.001) and fat free mass (OR
1.15, 95% CI 1.04 to 1.28, p ¼ 0.007) were both associated with a large
IPFP.
Conclusions: A larger IPFP predicts reduced lateral tibial cartilage vol-
ume loss and knee pain and mechanistically might function as a local
shock-absorber. The lack of association between measures of adiposity
and the size of the IPFP might suggest that the IPFP size is not simply a
marker of systemic obesity.
OA: Cartilage and Bone
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HIGH SYSTEMIC LDL CHOLESTEROL LEVELS DURING EXPERIMENTAL
OSTEOARTHRITIS LEAD TO INCREASED SYNOVIAL ACTIVATION AND
ECTOPIC BONE FORMATION AT END-STAGE OSTEOARTHRITIS,
WHILE EXCESSIVE LEVELS ACCELERATE DEVELOPMENT OF JOINT
PATHOLOGY ALREADY AT EARLY-STAGE OF OSTEOARTHRITIS
W. de Munter y, M.M. van den Bosch y, A.W. Sloetjes y,
P.M. van der Kraan y, T. Vogl z, J. Roth z, W.B. van den Berg y,
P.L. van Lent y. yRadboud Univ. Med. Ctr., Nijmegen, Netherlands; z Inst. of
Immunology, Muenster, Germany
Purpose: A relation between osteoarthritis (OA) and the metabolic
syndrome has long been established. One of the characteristics of the
metabolic syndrome is increased cholesterol levels. In a recent study, we
showed that LDL accumulationby LDL receptordeﬁcientmice resulted in
increased ectopic bone formation during experimental osteoarthritis.
In the present study we investigate OA pathology in ApoE deﬁcient
(ApoE-/-) mice with and without a cholesterol-rich diet, which is a
model for extremely high systemic LDL cholesterol levels.
Methods: Wild type (WT) and ApoE-/- mice received a normal or cho-
lesterol-rich diet for 54 days. At day 18, experimental OA was induced
by intra-articular injection of collagenase and animals were sacriﬁced at
day 28 and 54. Gene expression in synovium was measured by RT-PCR
and joint pathology was investigated by histology. LDL levels were
measured in serum and synovial wash-outs.
Results: ApoE-/- mice on a normal diet showed markedly higher LDL
levels than WT mice (8.90 mmol/L and 0.40 mmol/L, respectively;
p<0.001). While no differences between the two groups were found at
the early time point (day 28), end point OA (day 54) in ApoE-/- mice
showed a strong increase of ectopic bone formation, mainly at the
medial collateral ligament (fold increase 5.4; p<0.001) compared toWT
mice. No signiﬁcant differences in cartilage damage were found
between the two groups; a slight increase in synovial thickening,
however, was found in ApoE-/-mice (arbitrary score 1.9 versus 1.1 in WT
mice; p<0.05). Furthermore, synovial gene expression of both S100A8
and S100A9 (fold increase 1.8 and 1.4, respectively; p<0.05) and
S100A8/S100A9 protein levels of synovial wash-outs were increased in
ApoE-/- mice (fold increase 5.8; p<0.05), suggesting an activated status
of synovial lining cells.
In addition, we investigated whether a cholesterol-rich diet could
increase joint pathology after induction of OA. The diet increased LDL
levels even more in ApoE-/- mice (fold increase 2.1, compared to ApoE-/-
mice on a normal diet; p<0.001). In both ApoE-/- and WT mice on a
cholesterol-rich diet, excessive bone formationwas found in the medial
collateral ligament at day 54, however, no signiﬁcant difference was
found between the two groups. Interestingly, at the early time point
(day 28; 10 days after OA induction), histological differences between
the two groups were observed. Synovial thickening was four times
increased (p<0.001) in ApoE-/-mice on a cholesterol-rich diet and alsoectopic cartilage formation in the medial collateral ligament was
strongly increased (fold increase 2.7; p<0.01) compared to WT mice on
a cholesterol-rich diet.
Conclusions: LDL cholesterol accumulation by ApoE deﬁciency or a
cholesterol-rich diet results in increased synovial activation and ectopic
bone formation in experimental OA. Excessive LDL levels induced by a
combination of ApoE deﬁciency and a cholesterol-rich diet strongly
elevated synovial activation and ectopic bone formation at an early
stage of the disease without affecting cartilage destruction.
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EXPERIMENTAL EVALUATION OF DISCOIDIN DOMAIN RECEPTOR 2
AS AN IDEAL TARGET FOR DEVELOPMENT OF DISEASE-MODIFYING
OSTEOARTHRITIS DRUGS
L. Manning, L. Xu, Y. Li. Harvard Sch. of Dental Med. and Harvard Med.
Sch., Boston, MA, USA
Purpose: The goal of this study is to evaluate if the complete removal of
Ddr2 from the knee joint of mouse adult articular cartilage can delay
progression of osteoarthritis prior to or after initiation of articular car-
tilage degeneration. MMP-13, which has the ability to degrade both
aggrecans and type II collagen, would be an ideal target for disease-
modifying osteoarthritis drugs. However, the broad biological effects of
MMP-13 restrict its application as a target enzyme of inhibitor drugs in
the treatment of OA. Recent studies demonstrate that a speciﬁc amino
acid sequence, from amino acid 594 to 605, on type II collagen is pref-
erentially recognized by DDR2. The expression and subsequent activa-
tion of DDR2 were increased in human OA tissues and mouse models of
OA, and this was co-localized with elevated expression of MMP-13 in
degenerative articular cartilages. Conversely, reduced expression of Ddr2
in the heterozygous Ddr2 knockout condition attenuated progression of
articular cartilage degeneration in mouse models of OA. Typically, DDR2
is kept inactivated by the presence of the pericellular matrix, which
separates chondrocytes from type II collage in healthy articular cartilage.
Once enzymes, such as a serine proteinase, high temperature require-
ment A1, that are capable of degrading the pericellular molecules expose
chondrocytes to type II collagen, DDR2 is activated and then induces
expression of MMP-13 leading the degradation of type II collage and
proteoglycans resulting in joint destruction and OA.
Methods: 1) By use of conditional knock out techniques with aggrecan-
CreERt2 mice and ﬂoxed Ddr2 mice, Ddr2 was removed from articular
cartilage of knee joints in mice at 8 weeks of age via intraperitoneal
injection Tamoxifen injection (2mg/10g body weight) for 5 consecutive
days (Group A). Mice were subjected to destabilization of the medial
meniscus (DMM) or sham surgery at 10 weeks of age. 2) An additional
experimental group was subjected to DMM or sham surgery at 10
weeks of age and then Ddr2 was removed by intraperitoneal injection
Tamoxifen injection 8 weeks later (Group B). 3) Knee joints fromGroups
A and B mice and their corresponding controls (n¼7) were then col-
lected for morphological analysis. Knee joints from mice in Group A
were harvested at 8 weeks (n¼7) or 16 weeks (n¼9) post-surgery and
those from Group B (n¼5) at 16 weeks post-surgery. 4) Histology was
performed. 5) ORASI Modiﬁed Mankin Score was used to evaluate
articular cartilage degeneration. 6) Statistically signiﬁcant differences
were determined via T-test.
Results: 1) The average modiﬁed score for Group A 8 week control was
1.64 (score range 1.5-2) whereas the average modiﬁed score with Ddr2
removed was 0.64 (score range 0.5-1) [P<0.05]. 2) The averagemodiﬁed
score for Group A 16 week control was 4.67 (score range 4-5) and the
average modiﬁed score with Ddr2 removed was 1.27 (score range 0.5-3)
[P<0.05]. 3) The average modiﬁed score for Group Bwas 1.1 (score range
0.5-2).
Conclusions: Conditional removal of Ddr2 in articular cartilage atte-
nuated articular cartilage degeneration in mature knee joints of mouse
models of OA. Therefore, inhibiting activity of DDR2, may be considered
in treatment of OA in mature joints in humans.
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ASSOCIATION BETWEEN CARTILAGE DEGENERATION AND
SUBCHONDRAL BONE METABOLISM IN PATIENTS WITH KNEE
OSTEOARTHRITIS
M. Kretzschmar y,z, O. Maas z, G.B. Joseph y, D. Wild z. yUniv. of California
San Francisco, San Francisco, CA, USA; zUniv. Hosp. Basel, Basel,
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